⌘K

Login Start Free

Home/Filings/4/0001127602-22-008043

4//SEC Filing

Burton Paul 4

Accession 0001127602-22-008043

CIK 0001682852other

View on SEC.gov Company Profile

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 5:00 PM ET

Size

7.4 KB

Accession

0001127602-22-008043

Insider Transaction Report

Form 4

Period: 2022-03-01

Moderna, Inc.MRNA

Chief Medical Officer

Transactions

Award
Stock Option (Right to Buy)
2022-03-01+6,505→ 6,505 total
Exercise: $149.52From: 2023-03-01Exp: 2032-03-01→ Common Stock (6,505 underlying)
Award
Restricted Stock Units
2022-03-01+1,603→ 1,603 total
Exercise: $0.00→ Common Stock (1,603 underlying)

Footnotes (2)

[F1]25% of this option will vest and become exercisable on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
[F2]25% of the shares subject to this restricted stock unit award will vest on March 1, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

Moderna, Inc.

CIK 0001682852

Entity typeother

Related Parties

1

filerCIK 0001869869

Filing Metadata

Form type: 4
Filed: Mar 2, 7:00 PM ET
Accepted: Mar 3, 5:00 PM ET
Size: 7.4 KB

View on SEC.gov